Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion type Assertion NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_head.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion description "[In matching plasma samples using a PMR cut-off level of 0.01%, SEPT9 methylation was 8.3% (2/24) of NED, 30.8% (8/26) of adenoma and 88.2% (30/34) of CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_provenance.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion evidence source_evidence_literature NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_provenance.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion SIO_000772 25526039 NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_provenance.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion wasDerivedFrom befree-2016 NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_provenance.
- NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_assertion wasGeneratedBy ECO_0000203 NP1249689.RAH-dYNPdloQinJt_YKG4__bQwuoeNeShAVDwb21JAHyY130_provenance.